# Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients

> **NCT00531856** · PHASE2 · WITHDRAWN · sponsor: **Mallinckrodt**

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Inhaled carbon monoxide
- **DRUG:** Inhaled carbon monoxide
- **DRUG:** Inhaled carbon monoxide
- **DRUG:** Inhaled Carbon Monoxide
- **DRUG:** Inhaled Carbon Monoxide

## Key facts

- **NCT ID:** NCT00531856
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-08
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Clinical Hold pending additional data review and protocol amendment
- **Last updated:** 2016-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00531856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00531856, "Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00531856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*